ArticleOncogenesis2023

Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance.

Gang Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.